BMO plans 5.4% cash-settled autocallables tied to Nasdaq Biotech fund

By Susanna Moon

Chicago, March 23 – Bank of Montreal plans to price 5.4% autocallable cash-settled notes with fixed interest payments due March 29, 2018 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to an FWP filing with the Securities and Exchange Commission.

Interest is payable monthly.

The notes will be called at par if the fund closes above its 110% call level on any monthly review date.

The payout at maturity will be par unless the fund finishes below its initial level and ever closes below its 80% trigger level during the life of the notes, in which case investors be fully exposed to any losses.

BMO Capital Markets Corp. is the agent.

The notes will price on March 28 and settle on March 31.

The Cusip number is 06367TTG5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.